Frank Piscotta is a Staff Scientist I in the in vitro biology section of the Drug Discovery group at the Lieber Institute. After acquiring his B.E. in Chemical Engineering from The Cooper Union, he obtained his Ph.D. from Princeton University in 2018, where he worked in the laboratory of Dr. A. James Link. His thesis work investigated the unique lasso peptide class of natural products, as well as their related biosynthetic gene clusters. He then performed his postdoctoral research in the laboratory of Dr. Sean Brady at Rockefeller University, where he continued his work with natural products, this time pertaining to their roles within the human microbiome. In 2021, Frank arrived at the Lieber Institute, where he now leverages his background in chemistry and biology towards assay design, aiding in the identification of new drug targets and the characterization of novel therapeutics.